Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Infections × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 242 Carcinoma, Non-Small-Cell Lung 174 Prostatic Neoplasms 144 Lung Neoplasms 78 Stomach Neoplasms 59 Neoplasms 58 Squamous Cell Carcinoma of Head and Neck 47 Head and Neck Neoplasms 47 Esophageal Neoplasms 43 Neoplasm Metastasis 39 Ovarian Neoplasms 33 Pancreatic Neoplasms 25 Sarcoma 19 Urinary Bladder Neoplasms 16 Carcinoma, Ovarian Epithelial 16 Breast Neoplasms, Male 16 Adenocarcinoma Of Esophagus 15 Unspecified Adult Solid Tumor, Protocol Specific 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Esophageal Squamous Cell Carcinoma 12 Carcinoma, Squamous Cell 12 Adenocarcinoma of Lung 12 Fallopian Tube Neoplasms 11 Melanoma 10 Adenocarcinoma 10 Triple Negative Breast Neoplasms 9 Inflammatory Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Carcinoma, Renal Cell 8 Carcinoma 8

Interventions

Voriconazole 3 Vancomycin 3 Fluconazole 3 Ciprofloxacin 3 Trimethoprim, Sulfamethoxazole Drug Combination 2 Therapeutics 2 Piperacillin, Tazobactam Drug Combination 2 Granulocyte Colony-Stimulating Factor 2 Fosfomycin 2 Filgrastim 2 Caspofungin 2 Antibiotic Prophylaxis 2 ziprasidone 1 threonic acid 1 telavancin 1 soybean oil, phospholipid emulsion 1 plerixafor 1 monalizumab 1 liposomal amphotericin B 1 lime 1 human papillomavirus vaccine, L1 type 16, 18 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 fludarabine phosphate 1 fish oil triglycerides 1 drotrecogin alfa activated 1 avdoralimab 1 amphotericin B, deoxycholate drug combination 1 Zolpidem 1 X-Rays 1 Whole-Body Irradiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04324346 2021-03-18

PICC&PAC

Swedish Red Cross University College

Phase NA Completed

Infections, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡